SLRN Shares Outstanding History Table | ||||||||
Also see: SLRN Market Cap History SLRN YTD Return |
SLRN Shares Outstanding History Table | ||||||||
Also see: SLRN Market Cap History SLRN YTD Return |
SLRN Shares Outstanding History Chart | |||||||||
+0.36% CAGR Mouse over chart for data details
|
SLRN Stock Price Chart |
About ACELYRIN Inc |
ACELYRIN is engaged in the identification, acquisition, development and commercialization of medicines for autoimmune and inflammatory diseases. Co.'s clinical and preclinical stage product candidates consisting of: izokibep, which is a small protein therapeutic designed to inhibit anti-interleukin-17A; lonigutamab, which is a humanized immunoglobulin G1 (IgG1) monoclonal antibody against insulin-like growth factor 1 receptor for the treatment of chronic urticaria; and SLRN-517, which is a fully human IgG1 monoclonal antibody targeting c-KIT for the treatment of chronic urticaria. We show 3 historical shares outstanding datapoints in our coverage of SLRN's shares outstanding history. Understanding the changing numbers of SLRN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like SLRN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching SLRN by allowing them to research SLRN shares outstanding history as well as any other stock in our coverage universe. |
SLRN Current Stock Quote |
Free SLRN Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: Shares Outstanding Importance | |
|
SLRN Share Performance |
Shares Outstanding Peers |
ACELYRIN (SLRN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
SLRX Shares Outstanding History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.